Reference number : 033-2021-2022-Q4-816245, amendment number : 1, agreement type : O, recipient legal name : BioVectra Inc, recipient country : CA, recipient province : PE, recipient city : Charlottetown, recipient postal code : C1E0A1, program name english : SIF Stream2- Growth, program name french : FIS Volet 2- Croissance, program purpose english : -Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector., program purpose french : -favoriser les activités de R-D qui accéléreront le transfert de la technologie et la commercialisation de produits, de processus et de services novateurs ;-faciliter la croissance et l'expansion des entreprises au Canada ;-attirer et conserver des investissements de grande envergure au Canada ; et-faire progresser la recherche industrielle, le développement et la démonstration de technologies grâce à la collaboration entre les universitaires, les organisations à but non lucratif et le secteur privé., agreement title english : Canadian Vaccines and Biomanufacturing Center, agreement title french : Centre canadien des vaccins et de la biofabrication, agreement number : 816245, agreement value : 46472500.0, agreement start date : 2021-11-01, agreement end date : 2023-12-31, description english : This project will provide vital vaccines and therapies to Canadians by constructing a state-of-the-art biomanufacturing facility to close an existing gap in domestic production. The project will increase mRNA and pDNA vaccine production as well as establish capabilities to fill-and-finish vaccines., description french : Ce projet de construction d'une installation de biofabrication à  la fine pointe de la technologie pour combler une lacune existante dans la production nationale fournira des vaccins et des produits thérapeutiques essentiels aux Canadiens. Le projet permettra d'accroître la production de vaccins à  ARNm et à  ADNp et d'établir la capacité de mise en flacon et de conditionnement de vaccins., expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : ic, owner organization title : Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada